Literature DB >> 8365073

Financial and emotional cost of bronchopulmonary dysplasia.

K A McAleese1, M A Knapp, T T Rhodes.   

Abstract

Bronchopulmonary dysplasia (BPD) in infants with neonatal respiratory disease significantly increases the duration of hospitalization and cost of medical care. Early discharge on home oxygen therapy results in cost savings for third-party payers and the hospital, but adds financial and emotional burdens for the family. The median cost of initial hospitalization for 59 infants was $173,160 each. The median duration of home oxygen therapy was 92 days; the median cost was $5,195, compared with a projected cost of $46,920 for hospitalization for the same period. Two thirds of the 59 families experienced increased financial stress associated with marital status, reduced income, type of health insurance, and/or lack of respite or nursing help. Emotional stress was assessed in 26 (44%) of the families; one half coped well. Parents' perception of adequate insurance and stable income was significantly associated with positive coping. Providing home care for an infant with BPD on oxygen therapy is rewarding in many respects, but success requires appreciating its financial and emotional impact on families and providing them with social and financial support.

Entities:  

Mesh:

Year:  1993        PMID: 8365073     DOI: 10.1177/000992289303200702

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  12 in total

Review 1.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Home Oxygen and 2-Year Outcomes of Preterm Infants With Bronchopulmonary Dysplasia.

Authors:  Sara B DeMauro; Erik A Jensen; Carla M Bann; Edward F Bell; Anna Maria Hibbs; Susan R Hintz; Scott A Lorch
Journal:  Pediatrics       Date:  2019-04-11       Impact factor: 7.124

3.  Tracheobronchomalacia Is Associated with Increased Morbidity in Bronchopulmonary Dysplasia.

Authors:  Erik B Hysinger; Nicholas L Friedman; Michael A Padula; Russell T Shinohara; Huayan Zhang; Howard B Panitch; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2017-06-16

4.  Health Care and Societal Costs of Bronchopulmonary Dysplasia.

Authors:  Wannasiri Lapcharoensap; Henry C Lee; Amy Nyberg; Dmitry Dukhovny
Journal:  Neoreviews       Date:  2018-04

Review 5.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

6.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Authors:  Matthew M Laughon; John C Langer; Carl L Bose; P Brian Smith; Namasivayam Ambalavanan; Kathleen A Kennedy; Barbara J Stoll; Susie Buchter; Abbot R Laptook; Richard A Ehrenkranz; C Michael Cotten; Deanne E Wilson-Costello; Seetha Shankaran; Krisa P Van Meurs; Alexis S Davis; Marie G Gantz; Neil N Finer; Bradley A Yoder; Roger G Faix; Waldemar A Carlo; Kurt R Schibler; Nancy S Newman; Wade Rich; Abhik Das; Rosemary D Higgins; Michele C Walsh
Journal:  Am J Respir Crit Care Med       Date:  2011-03-04       Impact factor: 21.405

7.  Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia.

Authors:  Kristen A Tropea; Eva Leder; Muhammad Aslam; Allison N Lau; David M Raiser; Joo-Hyeon Lee; Vivek Balasubramaniam; Laura E Fredenburgh; S Alex Mitsialis; Stella Kourembanas; Carla F Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-10       Impact factor: 5.464

Review 8.  Predictors of bronchopulmonary dysplasia.

Authors:  Andrea Trembath; Matthew M Laughon
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430

9.  Development of a proxy-reported pulmonary outcome scale for preterm infants with bronchopulmonary dysplasia.

Authors:  Sara E Massie; Sue Tolleson-Rinehart; Darren A DeWalt; Matthew M Laughon; Leslie M Powell; Wayne A Price
Journal:  Health Qual Life Outcomes       Date:  2011-07-26       Impact factor: 3.186

Review 10.  Influences of environmental exposures on preterm lung disease.

Authors:  Joseph M Collaco; Brianna C Aoyama; Jessica L Rice; Sharon A McGrath-Morrow
Journal:  Expert Rev Respir Med       Date:  2021-06-17       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.